Hepatitis C Committee

Chair: Dr. P. Kishore, MD, MPH, CMA

(Boston NAMA)

Committee Members

Paul Bowman, CMA 

Cheri Jarvis, CMA 


The HCV Committee was created to empower methadone patients through education and advocacy and to provide support for those that do test positive for Hepatitis C.


What Is Hepatitis C?

  • Hepatitis is an inflammation of the liver. Although in many people the diseased liver is able to repair itself and regain function, it may progress to scarring of the liver and chronic liver disease. Hepatitis can have numerous causes. A common cause is infection with one of the several types of viruses (e.g., hepatitis A, B, or C viruses).
  • Hepatitis C virus (HCV) infection occurs when blood, or other body fluids from an infected person enters the body of an uninfected person. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old. Injection drug use and blood transfusion prior to 1992 are major risk factor for HCV infection. About 3.9 million American have been infected with HCV and 2.7 million have chronic infection. In 2000, about 30,000 new infections occurred. Most of these infections occurred among young adults 20-39 years old.
  • HCV infection is becoming a leading cause of cirrhosis. In addition to genetic factors in the infected person three independent factors are associated with an increased rate of disease progression. These factors include daily alcohol consumption, age at infection of more than 40 years, and male gender. These factors have a greater influence on progression to cirrhosis in HCV infection than the virus itself.

What Should You Do If You Have Hepatitis C?

  • There are several actions all people who have chronic viral hepatitis C should take as general measures. Most important of all is to not drink alcoholic beverages, and if necessary, get into treatment, because alcohol makes liver disease worse. Injection drug users should stop injecting drugs and get into and stay in substance abuse treatment. All individuals with chronic liver disease should be immunized against hepatitis A. Individuals with chronic HCV who are at risk also should be immunized against hepatitis B.

Surviving Hep C Group

This group is a support group with emphasis on Hepatitis C. Everyone is welcome to share their experience’s and stories in this group no matter what your status might be. Everyone is encouraged to share information and educational topics. Hepatitis C can be survived, but we have to empower ourselves with knowlege and be our own treatment advocates.

Come on and join NAMA’s hepatitis group and talk with others who have HCV.

http://groups.yahoo.com/group/SurvivingHepC/

Contact List Manager Cheri Jarvis, CMA

[email protected]


Important Documents


Info Facts


Info Facts are prepared by the HCV Committee and under the direction of Dr. Kishore.

Publications


Similar Posts

  • |

    Orlaam(LAAM) Alert

    Admin 06/17/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Focus On

    Admin 02/26/2023

    Issues To Focus On Massachusetts Restores Methadone Funding Highlights from a compromise budget plan unveiled by House and Senate leaders on Thursday The $22.3 billion plan would: Restore Medicaid funding for 36,000 people under MassHealth Basic; Preserve a popular prescription drug coverage program for the elderly; Repeal the voter-approved Clean Elections law; Tighten the Quinn…

  • Stop Stigma Now

    Admin 10/06/2022

    Our Mission Today over a million people in this country are suffering from an addiction to opiates. The fortunate ones are those who have sought treatment… those who take a single dose of medication each day to be free of opiate addiction. It was 50 years ago that a group of three doctors at Rockefeller…

  • NAMA Policy Statement: A Commentary on Federal Policy for Patients Receiving Over 100 mgs (Revised)

    Admin 09/23/2022

    There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration (FDA) for permission. In the early…

  • The NAMA Store

    Admin 01/01/2022

                Book of the Month Didn’t Find a Book? Search Amazon.Com’s Catalog 2.5-Million Titles Enter Keyword Or Browse by Subject And Press Go. NAMA is a proud affiliate of Amazon.Com Your purchase helps NAMA! A Classic and the book that started it…… Federal Regulation of Methadone Treatment by Richard A. Rettig and Adam…

  • |

    Single State Agencies

    Admin 07/02/2022

    Alabama Department of Mental Health and Mental Retardation Division of Substance Abuse Services Webpage Alaska Division of Behavioral Health Webpage Arizona Bureau of Substance Abuse Treatment and Prevention Services Webpage Arkansas Division of Behavioral Health Services Alcohol and Drug Abuse Prevention Website California Dept of Alcohol and Drug Programs Website Colorado Dept of Human Services…